1. Home
  2. NBIX vs MAA Comparison

NBIX vs MAA Comparison

Compare NBIX & MAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.61

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$126.45

Market Cap

15.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
MAA
Founded
1992
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
MAA
Price
$130.61
$126.45
Analyst Decision
Strong Buy
Buy
Analyst Count
22
18
Target Price
$180.82
$147.94
AVG Volume (30 Days)
901.1K
767.4K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
4.86%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$22.85
$2.67
Revenue Next Year
$10.36
$2.91
P/E Ratio
$27.09
$35.71
Revenue Growth
977.51
N/A
52 Week Low
$97.30
$120.30
52 Week High
$160.18
$169.00

Technical Indicators

Market Signals
Indicator
NBIX
MAA
Relative Strength Index (RSI) 50.14 51.36
Support Level $124.29 $125.75
Resistance Level $136.23 $136.72
Average True Range (ATR) 4.29 1.87
MACD -0.08 0.78
Stochastic Oscillator 59.64 87.67

Price Performance

Historical Comparison
NBIX
MAA

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.

Share on Social Networks: